The Shenzhen Saiaojin Cancer Hospital International Alliance is a cutting-edge hub for tumor diagnosis and treatment and technological innovation, positioned globally and rooted in the Guangdong-Hong Kong-Macao Greater Bay Area by the Sino-US Saiaojin Cancer Chain Group. Leveraging the group's core technologies in the biomedical field, global industrial resources, and international operational experience, the alliance focuses on precision tumor treatment and cell technology transformation, aiming to build an international tumor medical innovation platform integrating clinical practice, scientific research, and industry.